Abstract | BACKGROUND: Urine osmolality (U-OSM) is valuable to predict response to tolvaptan (TLV) in decompensated heart failure patients, but measurement of U-OSM is not always available on site. METHODS AND RESULTS: Data were collected from 66 hospitalized patients with decompensated heart failure who had received TLV at 3.75-15 mg/day. U-OSM, which was estimated using the following formula: 1.07×{2×[(urine sodium (mEq/L)]+[urine urea nitrogen (mg/dl)]/2.8+[urine creatinine (mg/dl)]×2/3}+16, was well correlated with the actual measurement (r=0.938, P<0.001). Criteria consisting of C1 (estimated baseline U-OSM>358 mOsm/L) and C2 (%decrease in estimated U-OSM>24% at 4-6 h after the first TLV dose) significantly discriminated responders from non-responders (P<0.05). CONCLUSIONS:
|
Authors | Teruhiko Imamura, Koichiro Kinugawa, Shun Minatsuki, Hironori Muraoka, Naoko Kato, Toshiro Inaba, Hisataka Maki, Taro Shiga, Masaru Hatano, Atsushi Yao, Shunei Kyo, Issei Komuro |
Journal | Circulation journal : official journal of the Japanese Circulation Society
(Circ J)
Vol. 77
Issue 5
Pg. 1208-13
( 2013)
ISSN: 1347-4820 [Electronic] Japan |
PMID | 23318562
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antidiuretic Hormone Receptor Antagonists
- Benzazepines
- Biomarkers
- Hormone Antagonists
- Tolvaptan
- Urea
- Sodium
- Creatinine
- Nitrogen
|
Topics |
- Aged
- Aged, 80 and over
- Antidiuretic Hormone Receptor Antagonists
- Benzazepines
(therapeutic use)
- Biomarkers
(urine)
- Chi-Square Distribution
- Creatinine
(urine)
- Female
- Heart Failure
(diagnosis, drug therapy, physiopathology, urine)
- Hormone Antagonists
(therapeutic use)
- Hospitalization
- Humans
- Male
- Middle Aged
- Models, Biological
- Nitrogen
(urine)
- Osmolar Concentration
- Retrospective Studies
- Sodium
(urine)
- Time Factors
- Tolvaptan
- Treatment Outcome
- Urea
(urine)
|